# Oncologic Drugs Advisory Committee Discussion on FDA Requirements or Approval of New Drugs for Treatment of Colon and Rectal Cancer - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/oncologic-drugs-advisory-committee-discussion-on-fda-requirements-or-approval-of-new-drugs-for-treatment-of-colon-and-rectal-cancer/4902e903-ac24-437e-a3f6-69c616094804

> FDA guidance document: Oncologic Drugs Advisory Committee Discussion on FDA Requirements or Approval of New Drugs for Treatment of Colon and Rectal Cancer. Issue date: March 02, 1998. Get complete insights and analysis.

---

## Details

- Title: Oncologic Drugs Advisory Committee Discussion on FDA Requirements or Approval of New Drugs for Treatment of Colon and Rectal Cancer
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1998-03-02
- Last Changed: 2019-04-01

## Related Documents

- [Format and Content of the Human Pharmacokinetics and Bioavailability Section of an Application](https://www.globalkeysolutions.net/guidances/guidance-document/format-and-content-of-the-human-pharmacokinetics-and-bioavailability-section-of-an-application/0fc0547b-5081-4033-af56-10b885a39a8f)
- [FDA Requirements for Approval of Drugs to Treat Non-Small Cell Lung Cancer](https://www.globalkeysolutions.net/guidances/guidance-document/fda-requirements-for-approval-of-drugs-to-treat-non-small-cell-lung-cancer/438d59a1-9648-4c99-b3f7-b21928a95608)
- [Preparation of Investigational New Drug Products (Human and Animal):  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/preparation-of-investigational-new-drug-products-human-and-animal-guidance-for-industry/4382914f-5b98-4ad4-91c1-ed6e2893e213)